The latest on the Covid-19 pandemic in the US
The biotechnology company Novavax has pushed back its plans to apply for emergency use authorization of its Covid-19 vaccine in the US to the fourth quarter of this year, according…
The biotechnology company Novavax has pushed back its plans to apply for emergency use authorization of its Covid-19 vaccine in the US to the fourth quarter of this year, according…